2nd EAC Regional Pharmaceutical Manufacturing Plan of Action 2017–2027: A regional roadmap to guide the East African Community towards evolving an efficient and effective regional pharmaceutical industry that can supply national, regional and international markets with efficacious and quality medicines.

Abstract

The EAC Regional Pharmaceutical Manufacturing Plan of Action (EAC-RPMPOA),2012-2016 was developed to serve as a road map to guide the community towards evolving in to an efficient and effective regional pharmaceutical manufacturing industry. The implementation of the plan along with other regional initiatives such as the EAC Medicines Registration Harmonization (MRH) and the EAC Industrialization Policy and Strategy (which prioritizes pharmaceutical sector) has contributed to the positive development of the sector and progress in harnessing joint economic potential. The implementation period for the first EAC-RPMPOA: 2012-2016 ended in 2016 and there is need for continuation and further improvement. This new plan (EAC-RPMPOA: 2017- 2027) therefore builds on the achievements of the first plan, identifies gains and challenges encountered and; lays down strategic approaches for the EAC and the Partner States. The plan factors in the Sustainable Development Goals (SDG) especially with regard to good health (SDG 3) and industry, innovation and infrastructure (SDG 9).